Compare MCK & DEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | DEO |
|---|---|---|
| Founded | 1833 | 1886 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4B | 47.8B |
| IPO Year | N/A | N/A |
| Metric | MCK | DEO |
|---|---|---|
| Price | $819.24 | $89.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $882.69 | $109.00 |
| AVG Volume (30 Days) | 828.7K | ★ 1.6M |
| Earning Date | 02-04-2026 | 02-03-2026 |
| Dividend Yield | 0.40% | ★ 4.60% |
| EPS Growth | ★ 66.19 | N/A |
| EPS | ★ 32.12 | 1.06 |
| Revenue | ★ $387,094,000,000.00 | $20,245,000,000.00 |
| Revenue This Year | $14.87 | $2.78 |
| Revenue Next Year | $8.32 | $3.49 |
| P/E Ratio | ★ $25.24 | $83.62 |
| Revenue Growth | ★ 17.23 | N/A |
| 52 Week Low | $558.36 | $85.13 |
| 52 Week High | $895.58 | $128.29 |
| Indicator | MCK | DEO |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 46.85 |
| Support Level | $801.21 | $88.35 |
| Resistance Level | $824.95 | $90.33 |
| Average True Range (ATR) | 16.74 | 1.60 |
| MACD | -2.27 | 0.25 |
| Stochastic Oscillator | 45.20 | 46.45 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Formed in 1997 through the merger of Grand Metropolitan and Guinness, Diageo is the largest distiller globally by sales. Diageo acquired some of the Seagram assets in 2001, which gave it brands such as Captain Morgan rum and Crown Royal Canadian whisky. Since then, mergers and acquisitions have mostly been bolt-on in nature, plugging gaps in the company's product and geographic portfolio. The firm has also shed noncore brands over the years, including the majority of its wine assets in 2015.